 |
|
|
| Poster session 1: Non Hodgkin's Lymphoma |
| Date: | Friday, 13 June 2003 |
| Time: | 17:00-18:30 |
| Room: | |
| 17:00-18:30 |
0280 |
|
|
A NOVEL PHENOXAZINE, 2-AMINO-4, 4A-DIHYDRO-4A, 7-DIMETHYL-3H-PHENOXAZINE-3-ONE, EXCERTS ANTI-TUMOR ACTIVITY AGAINST HUMAN B CELL AND T CELL LYMPHOBLASTOID CELL LINES
A. Tomoda, J. Koshibu-Koizumi, F. Mizuno, M. Takasaki (Tokyo, Japan)
| 17:00-18:30 |
0281 |
|
|
COMBINED THERAPY OF RITUXIMAB AND CHOP REPEATED EVERY 14-DAYS (R-CHOP 14) IS A SAFE AND EFFICACIOUS REGIMEN IN PATIENTS WITH ADVANCED DIFFUSE LARGE-B-CELL NON-HODGKIN'S LYMPHOMA
O. Ranze, H.G. Hoeffkes (Fulda, Germany)
| 17:00-18:30 |
0282 |
|
|
THE TREATMENT OF AGGRESSIVE NON-HODGKIN'S LYMPHOMAS OF THE ADULTS IN A COMMUNITY HOSPITAL PRACTICE: THE VACOP-B EXPERIENCE OF THE S.LUIGI HOSPITAL.
B.R. Bordonaro, N. Restuccia, R. Ricotta, A.M. Todaro, G. Petralia, G. Novello, S. Cordio, P. Salice, C. Giannitto-Giorgio, G. Lavenia, G. Blanco, F. Marletta, M. Manusia (Catania, Italy)
| 17:00-18:30 |
0283 |
|
|
FACTORS AFFECTING THERAPEUTIC RESPONSE AND SURVIVAL IN PATIENTS WITH INDOLENT NON-HODGKIN'S LYMPHOMA
M. Oltean, S. Demian, I. Macarie, M. Candea (Targu-mures, Romania)
| 17:00-18:30 |
0284 |
|
|
CASTELMAN'S DISEASE: THE PROGNOSTIC FACTORS
G. Gaman, A. Gaman, C. Besliu (Craiova, Romania)
| 17:00-18:30 |
0285 |
|
|
NON HODGKIN'S LYMPHOMA, REPORT OF 888 CASES DURING 23 YEARS (1977-2000)
WITH SPECIAL ATTENTION TO GASTROINTESTINAL LYMPHOMA
M.H. Salehi, H. Raziee (Mashhad, Iran)
| 17:00-18:30 |
0286 |
|
|
HAIRY CELL LEUKAEMIA DURING PREGNANCY. CASE REPORT AND REVIEW OF THE LITERATURE
B.A. Ali, J. Demeter, Z. Borbényi, L. Krenács, B. Pikó (Gyula, Hungary)
| 17:00-18:30 |
0287 |
|
|
CYSTATIN C CONCENTRATION AS POSSIBLE DIAGNOSTIC AND PROGNOSTIC MARKER OF TUMOR DEVELOPMENT
T.A. Usova, T.I. Pospelova, T.A. Korolenko, O.N. Poteryaeva (Novosibirsk, Russian Federation)
| 17:00-18:30 |
0288 |
|
|
RITUXIMAB PLUS CHOP AND ESHAP IN PATIENTS WITH HIGH-INTERMEDIATE-RISK AND HIGH-RISK AGGRESSIVE NON-HODGKIN'S LYMPHOMA
I. Intragumtornchai, P.R. Ponlapat Rojnuckarin, U.B. Udomsak Bunworasate (Bangkok, Thailand)
| 17:00-18:30 |
0289 |
|
|
EXPRESSION OF THE LUNG RESISTANCE PROTEIN IN HIGH GRADE B CELL NON-HODGKIN'S LYMPHOMAS
Z. Aki, S. Erdogan, S. Dagdas, M. Yilmaz, N. Guler, A. Akoz, G. Ozet, S. Ssckin, N. Zengin, M. Ayli, M. Yilmaz (Ankara, Turkey)
| 17:00-18:30 |
0290 |
|
|
QUANTIFICATION OF CIRCULATING CELLS BEARING MBR BREAKPOINT IN FOLLICULAR LYMPHOMA TREATED WITH FLUDARABINE, CYCLOPHOSPHAMIDE AND MITOXANTRONE (FCM)
C. Moreno, D. Colomer, N. Villamor, E. Domingo-Domčnech, J.M. Ribera, A. Altés, C. Estany, J. Besalduch, L. Escoda, C. Pedro, S. Gardella, A. Fernández de Sevilla, S. Montoto, A. López-Guillermo, E. Campo, E. Montserrat (Barcelona, Spain)
| 17:00-18:30 |
0291 |
|
|
MALT1 IS DEREGULATED BY BOTH CHROMOSOMAL TRANSLOCATION AND AMPLIFICATION IN B-CELL NON-HODGKIN LYMPHOMA
J.A. Martinez-Climent, D. Sanchez-Izquierdo, G. Buchonnet, R. Siebert, R.D. Gascoyne, J. Climent, E.L. Karran, M. Marin, A. Rosenwald, L.M. Staudt, M.Q. Du, D. Horsman, P. Marynen, D. Pinkel, J. Garcia-Conde, M.J.S. Dyer (Valencia, Spain)
| 17:00-18:30 |
0292 |
|
|
IL-2 INCREASES THE SUSCEPTIBILITY OF FRESHLY ISOLATED NEOPLASTOC B CELLS TO RITUXIMAB-MEDIATED ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY IN VITRO
J. Golay, M. Manganini, V. Facchinetti, R. Broady, G. Borleri, A. Rambaldi, M. Introna (Milano, Italy)
| 17:00-18:30 |
0293 |
|
|
TREATMENT OF CUTANEOUOS T-CELL LYMPHOMAS WITH PURINE ANALOGUES (FLUDARABINE AND 2-CHLORODEOXYADENOSINE)
G. Mazur, J. Maj, A. Hryncewicz-Gwozdz, E. Niezgoda, T. Wrobel, K. Kuliczkowski (Wroclaw, Poland)
| 17:00-18:30 |
0294 |
|
|
INCREASED SERUM LEVEL OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND MONOCYTE CHEMOTACTIC PROTEIN - 1 (MCP-1) IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA
G. Mazur, T. Wrobel, L. Usnarska-Zubkiewicz, K. Kuliczkowski (Wroclaw, Poland)
| 17:00-18:30 |
0295 |
|
|
PROGNOSTIC VALUE OF FOLLICULAR LYMPHOMA INTERNATIONAL PROGNOSTIC INDEX (FLIPI) IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL) AT FIRST PROGRESSION
S. Montoto, A. López-Guillermo, A. Altés, G. Perea, A. Ferrer, M. Camós, L. Villela, R. Martino, J. Esteve, F. Bosch, F. Cervantes, J. Bladé, E. Campo, J. Sierra, E. Montserrat (Barcelona, Spain)
| 17:00-18:30 |
0296 |
|
|
INTENSIFIED CHOP (CHOP14) PLUS RITUXIMAB IN THE TREATMENT OF ELDERLY PATIENTS WITH AGGRESSINE NON-HODGKIN'S LYMPHOMA (NHL)
L. Rigacci, R. Alterini, V. Carrai, L. Nassi, A. Carpaneto, A. Bosi (Florence, Italy)
| 17:00-18:30 |
0297 |
|
|
PROGNOSTIC VALUE OF ERYTRHROCYTE SEDMENTATION RATE IN NON-HODGKIN`S LYMPHOMA
A. Ivanaj (Tirana, Albania)
| 17:00-18:30 |
0298 |
|
|
PREDICTIV MODEL FOR AGGRESSIVE NON-HODGKIN'S LYMPHOMA (SINGLE CENTER EXPERIENCE)
S. Genadieva-Stavrik, N. Siljanovski, A. Stojanovic, B. Georgievski, M. Ivanovski, I. Panovska, Z. Stojanoski, M. Lozance, A. Crcareva, G. Zografski, Lj. Ivkovski, L. Cevreska (Skopje, Macedonia)
| 17:00-18:30 |
0299 |
|
|
PREVALENCE OF B-HERPESVIRUS INFECTIONS IN PATIENTS WITH CHRONIC B-CELL LYMPHOPROLIFERATIVE DISEASES
S. Lejniece, S. Kozireva, M. Murovska (Riga, Latvia)
| 17:00-18:30 |
0300 |
|
|
CLINICAL SIGNIFICANCE AND COMPARISON OF GALLIUM 67 SCANS WITH COMPUTARIZED TOMOGRAPHY IN PATIENTS WITH MALIGNANT LYMPHOMA
A.U. Unal, B. Eser, F. Altintas, M. Kula, I. Sari, O. Canoz, O. Kontas, A. Coskun, M. Cetin, A. Tutus (Kayseri, Turkey)
| 17:00-18:30 |
0301 |
|
|
MOLECULAR MONITORING T(14;18) AND CORRELATION BETWEEN CLINICAL AND MOLECULAR RESPONSE IN FOLLICULAR LYMPHOMA AFTER CHEMOTHERAPY
O.A. Oborilova, J. Mayer, D. Dvorakova, T. Cernova, I. Vasova, M. Navratil (Brno, Czech Republic)
| 17:00-18:30 |
0302 |
|
|
PLATELED DERIVED GROWTH FACTOR LEVEL IN HODGKIN DISEASE AND NON-HODGKIN LYMPHOMA AND IT'S IMPACT ON THE DISEASE ACTIVATION
N. Guler, S. Yilmaz, S. Ayaz, M. Yilmaz, Z. Aki, S. Dagdas, A. Akoz, G. Ozet, M. Ayli (Ankara, Turkey)
| 17:00-18:30 |
0303 |
|
|
PRIMARY B CELL CUTANEOUS LYMPHOMA. DIAGNOSIS,TREATMENT AND OUTCOME IN ADDENBROOKE'S HOSPITAL 1994 - 2002.
J. Okeeffe (Cambridge, United Kingdom)
| 17:00-18:30 |
0304 |
|
|
RITUXIMAB, GEMCITABINE AND OXALIPLATIN (R-GEMOX): A NEW SALVAGE REGIMEN FOR REFRACTORY/RELAPSED B-CELL LYMPHOMA. A PILOT STUDY
T. El Gnaoui, K. Belhadj, M. Lapeyre, I. Gaillard, M. Diviné, C. Copie-Bergman, B. Joly, A. Allain, F. Reyes, C. Haioun (Creteil, France)
| 17:00-18:30 |
0305 |
|
|
EFFICIENCY OF IN VIVO PURGING WITH RITUXIMAB FOLLOWED BY HIGH-DOSE THERAPY (HDT) WITH AUTOLOGOUS PERIPHERAL BLOOD STEM CELL (PBSC) TRANSPLANTATION IN B-CELL LYMPHOMAS. A SINGLE INSTITUTION STUDY
K. Belhadj, M.H. Delfau-Larue, T. El Gnaoui, F. Beaujean, J.L. Beaumont, C. Pautas, I. Gaillard, Y. Kirova, A. Allain, P. Gaulard, J.P. Farcet, F. Reyes, C. Haioun (Creteil, France)
| 17:00-18:30 |
0306 |
|
|
TREATMENT OF PATIENTS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) WITH A SEQUENTIAL TREATMENT CONSISTING OF ANTI CD20 ANTIBODY RITUXIMAB AND CHOP G-CSF CHEMOTHERAPY
S.H. Oertel, M. Papp-Vary, P. Reinke, U. Jaeger, E. Verschnuuren, M. Hummel, I. Anagnostopoulos, S. Choquet, H. Poirel, B. Doerken, H.B. Riess (Berlin, Germany)
| 17:00-18:30 |
0307 |
|
|
PROCALCITONIN LEVELS ARE NOT INCREASED IN PATIENTS WITH MALIGNANT LYMPHOMA AND NON-INFECTIOUS FEVER
M. Shtalrid, M.Z. Haran, A. Berrebi (Rehovot, Israel)
| 17:00-18:30 |
0308 |
|
|
TREATMENT OF PATIENTS WITH LOW-GRADE OR FOLLICULAR NON-HODGKIN'S LYMPHOMA WITH MABTHERA (ANTI CD20 MONOCLONAL ANTIBODY) AND CHOP CHEMOTHERAPY
O. Ionita, L. Cheveresan, I. Ionita, M. Cheveresan, C. Cotoraci, R. Mihaescu, M. Ionita (Timisoara, Romania)
| 17:00-18:30 |
0309 |
|
|
COMPLETE REMISSION OF A REFRACTORY BURKITT LYMPHOMA IN A 5 YEAR-OLD GIRL TREATED WITH RITUXIMAB, POLYCHEMOTHERAPY AND ALLOGENIC TRANSPLANT
C. Paillard, J.L. Stephan, A. Tchrkov, N. Boiret, J. Kanold, F. Demeocq (Clermont Ferrand, France)
| 17:00-18:30 |
0310 |
|
|
A PHASE II CLINICAL TRIAL ON EFFICACY AND TOXICITY OF CHOP WITH LIPOSOMAL DOXORUBICIN IN PATIENTS WITH AGGRESSIVE NHL AND IMPAIRED CARDIAC FUNCTION
V.B. Bakaloudi, M. Papaioannou, E. Hatjiharissi, D. Mihou, C. Tsimirika, E. Georgiou, D. Platogiannis, N. Constantinou, K. Zervas, T. Bishiniotis, J.I. Christakis (Thessaloniki, Greece)
| 17:00-18:30 |
0311 |
|
|
PROSPECTIVE SEARCH FOR SILENT "MARGINAL" B-CELL CLONES IN PATIENTS WITH HEPATITIS C VIRUS (HCV) INFECTION: DETECTION OF A FIRST CASE AMONG 28 SUBJECTS STUDIED
R. Bassan, B. Paris, G. Locatelli, G. Borleri, A. Salvi, M. Strazzabosco, T. Barbui (Bergamo, Italy)
| 17:00-18:30 |
0312 |
|
|
FIRST-LINE TREATMENT OF STAGE III-IV FOLLICULAR PATIENTS WITH THE FLUDARABINE CONTAINING REGIMEN FMD/FC
M.J. Terol, M. Marin, I. Marugan, M. Tormo, S. Duran, A. Leon, J. Moraleda, A. Bedańa, A. Torres, M.A. Cruz, J. Garcia-Conde (Valencia, Spain)
| 17:00-18:30 |
0313 |
|
|
PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: A CLINOPATHOLOGIC AND MOLECULAR STUDY OF 20 PATIENTS
S. Ostojic, R. Kusec, A. Planinc-Peraica, R. Ajdukovic, I. Aurer, M. Dominis, B. Jaksic (Zagreb, Croatia)
| 17:00-18:30 |
0314 |
|
|
CHLORAMBUCIL PLUS RITUXIMAB IN INDOLENT NON-HODGKIN'S LYMPHOMA: A PILOT STUDY
D.l. Laszlo, G.M. Martinelli, A.A. Agazzi, P.M. Mancuso, A.C. Calleri, A.V. Vanazzi, P.S. Santoro, F.B. Bertolini, E. Zucca, F.C. Cavalli (Milan, Italy)
| 17:00-18:30 |
0315 |
|
|
UNCOMMON NK-CELL LYMPHOMA WITH ATYPICAL PRESENTATION AND FULMINATING CLINICAL COURSE: A CASE REPORT
V. Tini, C. De Gregoris, L. Scaramucci, P. Niscola, R. Ciafrino, V. Bongarzoni, M. Morucci, M. Montanaro (Montefiascone (viterbo), Italy)
| 17:00-18:30 |
0316 |
|
|
INTENSIVE CHEMOTHERAPY WITH RITUXIMAB IN AIDS NON-HODGKIN'S LYMPHOMA
J. Rey, C.A. Charbonnier, S.C.J.M. Schiano de Collela, S.A.M. Stoppa, P.M.I. Poizot-Martin, G.J.A. Gastaut, C.R.T Costello (Marseille, France)
| 17:00-18:30 |
0317 |
|
|
LIPOSOMAL ANTHRACYCLINE IN THE TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
X.L. Leleu, F. Kuhnovski, L. Terriou, S. Depil, T. Gastinne, A.I. Yakoub-Agha, G.G. Guillerm, H.P. Huyghe, B.Q. Quesnel, F. Bauters, M.F. Morschhauser, T. Facon, X. Leleu (Lille, France)
| 17:00-18:30 |
0318 |
|
|
ANTI - CD 20 MONOCLONAL ANTIBODY COMBINED WITH CONVENTIONAL AND HIGH DOSE CHEMOTHERAPY IN B CELL LYMPHOMA IN 34 PATIENTS TREATED IN HEMATOLOGY DEPARTMENT IN KRAKOW
A. Zaluska, W. Jurczak, E. Zdzilowska, D. Krochmalczyk, I. Florek, A.B. Skotnicki (Kraków, Poland)
| 17:00-18:30 |
0319 |
|
|
AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION FOR THE TREATMENT OF AGGRESSIVE NON-HODGKIN'S LYMPHOMA
J. Holowiecki, S. Giebel, M. Krawczyk-Kulis, J. Walewski, J. Romejko, B. Stella-Holowiecka, J. Wojnar, A. Hellmann, J. Czyz, A. Skotnicki, W. Jurczak, A. Dmoszynska, M. Wach, K. Sulek, W. Jedrzejczak, C. Szczylik, T. Robak, K. Warzocha, B. Marianska, M. Wojciechowska (Katowice, Poland)
| 17:00-18:30 |
0320 |
|
|
RELAPSE OF A LMP 1-POSITIVE FOLLICULAR LYMPHOMA AFTER IMMUNOSUPPRESSION FOR HEPATITIS-ASSOCIATED APLASTIC ANAEMIA
I. Krsnik, M. López-Rubio, J. García-Suárez, D. de Miguel (Alcalá De Henares (madrid), Spain)
| 17:00-18:30 |
0321 |
|
|
SPLENIC AND NODAL MARGINAL ZONE LYMPHOMA (MZL) ARE INDOLENT DISORDERS AT HIGH HCV-SEROPREVALENCE WITH DISTINCT PRESENTING FEATURES, PATTERN OF DISSEMINATION, AND OUTCOME
L. Arcaini, M. Paulli, E. Boveri, D. Vallisa, P. Bernuzzi, E. Orlandi, P. Incardona, E. Brusamolino, F. Passamonti, S. Burcheri, C. Schena, C. Pascutto, L. Cavanna, U. Magrini, M. Lazzarino (Pavia, Italy)
| 17:00-18:30 |
0322 |
|
|
PRIMARY GASTRIC NON HODGKIN LYMPHOMA. CLINICO-PATHOLOGICAL STUDY AND EVALUATION OF PROGNOSTIC FACTORS
D. Petranovic, M. Prebilic-Sever, A. Duletic-Nacinovic, D. Kovac, I. Seili-Bekafigo, D. Petranovic (Rijeka, Croatia)
| 17:00-18:30 |
0323 |
|
|
DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN PATIENTS >60 YEARS OF AGE. RETROSPECTIVE ONE INSTITUTION RESULTS OF CHOP-21 REGIMEN. IS INTENSIFICATION OF THE TREATMENT NECESSARY?
I.V. Vasova, Z. Koristek, M. Navratil, J. Mayer, M. Klabusay, Z. Kral, T. Cernova, A. Oborilova, D. Salek (Brno, Czech Republic)
| 17:00-18:30 |
0324 |
|
|
EFFICACY OF CHOP REGIMEN, AS A FIRST LINE THERAPY, IN POST-TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS (PTLD). A RETROSPECTIVE STUDY ON 25 CASES
S. Choquet, S. Oertel, V. Levy, F. Davy, M. Raphael, V. Leblond (Le Chesnay, France)
| 17:00-18:30 |
0325 |
|
|
SERUM PHOSPHOLIPID ARACHIDONIC ACID AND DOCOSAHEXAENOIC ACID AS THE PROGNOSTIC FACTORS IN PATIENTS WITH NON HODGKIN'S LYMPHOMA
Z.C. Cvetkovic, V. Tepsic, V. Ristic, M. Petrovic (Belgrade, Serbia)
| 17:00-18:30 |
0326 |
|
|
THE CLINICAL APROACH TO EXTRANODAL NON HODGKIN'S LYMPHOMAS
A. Timuragaoglu, H. Bekoz, I. Karadogan, L. Undar (Antalya, Turkey)
| 17:00-18:30 |
0327 |
|
|
RITUXIMAB (MABTHERA) MAINTENANCE FOR PATIENTS WITH LOW GRADE NON-HODGKIN'S LYMPHOMA: AN EXPERIENCE IN THE NORTHEAST OF BRAZIL
P.F.T.F Costa (Fortaleza, Brazil)
| 17:00-18:30 |
0328 |
|
|
GORSKI KOTAR - ENDEMIC REGION FOR PRIMARY GASTRIC LYMPHOMA?
D. Petranovic, M. Sever-Prebilic, A. Duletic-Nacinovic, D. Pahor, S. Segulja, D. Petranovic (Rijeka, Croatia)
| 17:00-18:30 |
0329 |
|
|
MOST OF PRIMARY SALIVARY GLAND MALT LYMPHOMA ARE ASSOCIATED EITHER WITH SJOEGREN SYNDROME OR HCV INFECTION
A. Ambrosetti, R. Zanotti, L. Lenzi, M. Chilosi, M. Lazzarino, P. Caramaschi, E. Orlandi, L. Arcaini, F. Pasini, M. D'Adda, G. Pizzolo (Verona, Italy)
| 17:00-18:30 |
0330 |
|
|
ALLELIC FREQUENCY OF SINGLE NUCLEOTIDE POLYMORPHISMS IN MDR1 GENE IN PATIENTS WITH NON-HODGKIN`S LYMPHOMAS
O.B. Goreva, A.Y. Grishanova, V.V. Lyakhovich (Novosibirsk, Russian Federation)
| 17:00-18:30 |
0331 |
|
|
CUTANEOUS B-CELL LYMPHOMA ASSOCIATED WITH HEPATITIS C VIRUS (HCV) INFECTION
P. Bernuzzi, D. Vallisa, A. Lazzaro, R. Bertč, G. Civardi, C.F. Moroni, E. Anselmi, A. Arcari, L. Cavanna (Piacenza, Italy)
| 17:00-18:30 |
0332 |
|
|
COEXISTENCE OF SPLENIC MARGINAL ZONE LYMPHOMA AND MYELOID DISEASES.
A DESCRIPTION OF 3 OBSERVATIONS
L. Vila, E. Homolle, C. Charrin, D. Treille-Ritouet, X. Thomas, P.A. Bryon (Lyon, France)
| 17:00-18:30 |
0333 |
|
|
PHENOTYPE AND KINETICS OF CD34 HEMATOPOIETIC STEM CELLS IN PATIENTS WITH LYMPHOMA UNDERGOING MOBILIZATION OF PBSC WITH CYCLOPHOSPHAMIDE, ETOPOSIDE AND SC-70935 OR G-CSF
M. Klabusay, D. Lysak, Z. Koristek, Z. Fojtik, J. Mayer (Brno, Czech Republic)
| 17:00-18:30 |
0334 |
|
|
IMMUNOCHEMOTHERAPY FOR PRIMARY CNS LYMPHOMA (PCNSL)
S.J. Jankovic, B. Mihaljevic, R. Jancic-Nedeljkov, G. Milivojevic, V. Vujicic, V. Cemerikic, D. Boskovic, M. Petrovic (Belgrade, Serbia)
| 17:00-18:30 |
0335 |
|
|
CLINICOPATHOLOGICAL FEATURES OF PRIMARY BONE NON-HODGKIN'S LYMPHOMA
V. Cemerikic-Martinovic, B. Mihaljevic, R. Nedeljkov-Jancic, S. Jankovic, G. Milivojevic, V. Vujicic, M. Perunicic-Jovanovic, M. Atanackovic, J. Sopta, M. Petrovic, D. Boskovic (Belgrade, Serbia)
| 17:00-18:30 |
0336 |
|
|
INCREASED FREQUENCY OF EXTRANODAL INVOLVEMENT, BOTH, AT PRESENTATION AND AT RELAPSE FOR PATIENTS WITH PRIMARY TESTICULAR NON HODGKIN'S LYMPHOMA (NHL)
A. Symeonidis, S. Kougelou, M. Melachrinou, A. Kouraklis-Symeonidis, N. Giannakoulas, E. Fragopanagou, M. Tiniakou, P. Matsouka, N. Zoumbos (Patras, Greece)
| 17:00-18:30 |
0337 |
|
|
TREATMENT RESULTS OF LYMPHOMA MALIGNUM ( NHL-B) BURKITT TYPE IN CHILDREN.
A REPORT OF THE POLISH PEDIATRIC LEUKEMIA/LYMPHOMA STUDY GROUP (PPLLSG)
E. Sowinska, B. Kazanowska, M. Jelen, J. Maldyk, H. Bubala, A. Dluzniewska, A. Koltan, S. Papadiuk, A. Ploszynska, K. Roslan, B. Sopylo, E. Stanczak, J. Stefaniak, K. Stefanska, A. Chybicka (Wroclaw, Poland)
| 17:00-18:30 |
0338 |
|
|
EXPRESSION OF EPSTEIN-BARR VIRUS IN NONIMMUNOCOMPROMISED PATIENTS WITH NON HODGKIN LYMPHOMA
A. Duletic-Nacinovic, M. Sever-Prebilic, D. Petranovic, I. Host (Rijeka, Croatia)
| 17:00-18:30 |
0339 |
|
|
FOLLOW-UP OF AUTOLOGOUS STEM CELL TRANSPLANTATION (SCT) FOR TREATMENT OF WALDENSTR™M'S MACROGLOBULINEMIA
P.D. Dreger, B. Seyfarth, R. Sonnen, M. Zeis, R. Schoch, N. Schmitz (Hamburg, Germany)
| 17:00-18:30 |
0340 |
|
|
FAVORABLE OUTCOME OF PATIENTS WITH CUTANEOUS B-CELL LOW GRADE LYMPHOMAS (CBCL) TREATED WITH INTRALESIONAL RITUXIMAB ADMINISTRATION
M.-C. Kyrtsonis, M.N. Dimopoulou, M.P. Siakantaris, P. Korkolopoulou, S.I. Kokoris, E.M Dimitriadou, G.A Pangalis (Athens, Greece)
| 17:00-18:30 |
0341 |
|
|
RADIATION AND RITUXIMAB HAVE ADDITIVE CYTOTOXIC AND PROAPOPTOTIC EFFECTS ON B CELL LYMPHOMA CELL LINES IN VITRO
B. Glass, S. Dingeldein, M. Rave-Fränk, J. Hasenkamp, A. Rokita, H. Schmidberger (Göttingen, Germany)
| 17:00-18:30 |
0342 |
|
|
ADULT T-CELL LEUKEMIA/LYMPHOMA (ATLL):REPORT OF TWO FULLY DOCUMENTED HELLENIC PATIENTS
S.I. Kokoris, M.P. Siakantaris, F.N. Kontopidou, M.-C. Kyrtsonis, K. Anargyrou, A. Tsakris, N. Spanakis, T.P. Vassilakopoulos, E. Viniou, P. Korkolopoulou, E. Patsiouris, N. Legakis, G.A. Pangalis (Athens, Greece)
| 17:00-18:30 |
0343 |
|
|
PROGNOSTIC VALUE OF INTERLEUKIN-6 IN PATIENTS WITH INDOLENT AND AGGRESSIVE NON-HODGKIN LYMPHOMA
A. Nacinovic-Duletic, A. Duletic-Nacinovic, M. Sever-Prebilic, S. Stifter, I. Seili-Bekafigo, I. Host, D. Petranovic, N. Jonjic (Rijeka, Croatia)
| 17:00-18:30 |
0344 |
|
|
EXPRESSION OF CD27 IN MATURE B LYMPHOPROLIFERATIVE DISORDERS
B. Drénou, E. Le Breton, L. Amiot, O. Fardel, M. Bernard, T. Lamy, R. Fauchet (Rennes Cedex 09, France)
| 17:00-18:30 |
0345 |
|
|
EBV-INDUCED NON-HODGKIN LYMPHOMA IN AN X-LINKED THROMBOCYTOPENIA (XLT)
B. Drénou, P. Tattevin, A. El Bouchiki, M. Bernard, S. Caulet-Maugendre, C. Dauriac, S. Odent, M. Raphael, R. Fauchet (Rennes Cedex 09, France)
| 17:00-18:30 |
0346 |
|
|
ASSOCIATION OF HAIRY CELL LEUKEMIA AND CHRONIC LYMPHOCYTIC LEUKEMIA
N. Villamor, F. Bosch, D. Colomer, E. Giné, M. Rozman, M. Aymerich, A. López-Guillermo, E. Campo, E. Montserrat (Barcelona, Spain)
|